Evidence map›Paper›PMID 38910793›Full record

ArticleProceedings (Baylor University. Medical Center)2024

Impact of COVID-19 on pregnancy outcomes during delivery admissions: a nationwide analysis with clinical implications.

Shiza Virk, Adeel Nasrullah, Karthik Gangu, Aaisha Shah, Margaret Roth, Anam Javed, Muhammad Ibraiz Bilal, Muhammad Quazi, Asif Farooq, Tariq Cheema and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shiza VirkDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Adeel NasrullahDivision of Pulmonology and Critical Care, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-7604-6978
Karthik GanguDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Aaisha ShahDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Margaret RothDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Anam JavedDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Muhammad Ibraiz BilalDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Muhammad QuaziDepartment of Mathematics and Statistics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Asif FarooqDepartment of Family and Community Medicine, Texas Tech Health Science Center, Lubbock, Texas, USA.
Tariq CheemaDivision of Pulmonology and Critical Care, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Zain Bin IftikharFoundation University Islamabad, Pakistan.
Abu Baker SheikhDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The available literature indicates a link between SARS-CoV-2 infection during pregnancy and a heightened probability of experiencing negative outcomes for both the pregnant patient and the developing fetus. We compared clinical outcomes of pregnant patients with or without COVID-19 hospitalized during delivery. Methods: Multivariate logistic regression analysis was used to compare outcomes and was adjusted for patient-related, hospital-related, and illness severity indicators. Results: We identified a total of 3,447,771 pregnant patients admitted between January 1, 2020 and December 31, 2020; 1.3% (n = 46,050) had COVID-19. COVID-19-positive patients had higher rates of in-hospital mortality (0.15% vs 0.05%, adjusted odds ratio [aOR] 5.97, 95% confidence interval [CI] 2.5-14.25, Discussion: Clinicians should be aware of the heightened risk of complications in pregnant patients with COVID-19 and consider strategies to mitigate them.

Indexed as

COVID-19delivery admissionsin-hospital mortalitymaternal complicationsNational Inpatient Samplepregnancy outcomes

Identifiers

PMID38910793
PMCPMC11188827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.